Stay updated on Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial
Sign up to get notified when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.

Latest updates to the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedNew navigation/help sections were added and the Intervention/Treatment header was standardized (Intervention / Treatment to Intervention/Treatment), and the Revision tag was updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check15 days agoChange DetectedThe footer now displays Revision: v3.5.5 instead of Revision: v3.5.4, indicating a small page/version update. This change is metadata-related and does not modify the study information or user workflow.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision tag 'Revision: v3.5.4' was added and the previous tag 'Revision: v3.5.3' was removed. This indicates a routine platform update to the page rather than changes to trial content.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, indicating a minor page update or patch.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded revision label v3.5.2 and removed revision v3.5.0.SummaryDifference0.1%

- Check93 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.